Evidence map›Paper›PMID 41141472›Full record

ArticleHealth science reports2025

Global Health Effects of Osteopenia and Osteoporosis, 1990-2021.

Saeid Safiri, Fatemeh Amiri, Nahid Karamzad, Mark J M Sullman, Mohammad Rahmanian, Reza Aletaha, Mohammad Ali Mansournia, Gary S Collins, Fikrettin Şahin, Ali-Asghar Kolahi

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saeid SafiriSocial Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran.
Fatemeh AmiriAging Research Institute Tabriz University of Medical Sciences Tabriz Iran.
Nahid KaramzadNutrition Research Center, Department of Biochemistry and Diet Therapy, School of Nutrition and Food Sciences Tabriz University of Medical Sciences Tabriz Iran.
Mark J M SullmanDepartment of Life and Health Sciences University of Nicosia Nicosia Cyprus.
Mohammad RahmanianGastroenterology and Liver Diseases Research Center, Research, Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-0024-1934
Reza AletahaSocial Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran.
Mohammad Ali MansourniaDepartment of Epidemiology and Biostatistics, School of Public Health Tehran University of Medical Sciences Tehran Iran.
Gary S CollinsCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Botnar Research Centre University of Oxford Oxford UK.ORCID https://orcid.org/0000-0002-2772-2316
Fikrettin ŞahinDepartment of Genetics and Bioengineering Yeditepe University İstanbul Turkey.
Ali-Asghar KolahiSocial Determinants of Health Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Osteopenia and osteoporosis present a significant global public health challenge. This study analyses the global, regional, and national burden of disease attributable to low bone mineral density, including both osteopenia and osteoporosis, across 204 countries and territories from 1990 to 2021. Methods: Data were used to quantify deaths and disability-adjusted life years (DALYs) linked to osteopenia and osteoporosis. Results: In 2021, osteopenia and osteoporosis were responsible for 459,661 deaths and 17.3 million DALYs globally, with population attributable fractions of 0.7% and 0.6%, respectively. The global age-standardized death rate was 5.7 per 100,000, while the age-standardized DALY rate was 205 per 100,000, reflecting declines of 9.4% and 14.8%, respectively, from 1990 to 2021. The highest age-standardized DALY rates were seen in Saudi Arabia and India, while the lowest were in Azerbaijan and Jamaica. Significant increases in DALY rates were noted in Lesotho and the Netherlands, whereas the largest decreases occurred in Hungary and Taiwan. DALY rates for osteopenia and osteoporosis were highest in the 95+ age group for both sexes, with females generally experiencing higher rates, particularly in older age groups. The main contributing causes varied by age, with falls being the leading cause in the 80-84 age group, road injuries in the 40-44 age group, and exposure to mechanical forces in the 50-54 age group. A negative correlation was observed between regional socio-demographic index and age-standardized DALY rates from 1990 to 2021. Conclusion: Addressing the global burden of osteopenia and osteoporosis requires targeted interventions, further research, and efforts to reduce regional disparities and improve healthcare access.

Indexed as

bone densityepidemiologyglobal healthosteoporosisrisk factors

Identifiers

PMID41141472
PMCPMC12546677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.